*Result*: Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy
*Title*:
*Author/editor-in-chief*:
*Publication*:
Freiburg : Universität, 2023
*Physical description scale*:
1 Online-Ressource
*Format*:
*Language*:
*eng*
*Notes*:
Journal of experimental medicine. - 220, 12 (2023) , e20231235, ISSN: 1540-9538
*DOI*:
10.1084/jem.20231235